Europe — EMA
Apo-Go Pod (Apomorphine Hydrochloride Hemihydrate)
Apo-Go Pod contains Apomorphine Hydrochloride Hemihydrate, a medication used for managing symptoms of Parkinson's disease. It is administered subcutaneously for
Request sourcing
What is Apomorphine Hydrochloride Hemihydrate?
Apo-Go Pod contains Apomorphine Hydrochloride Hemihydrate, a medication used for managing symptoms of Parkinson's disease. It is administered subcutaneously for effective symptom control.
What is Apomorphine Hydrochloride Hemihydrate used for?
Apo-Go Pod is primarily used for the treatment of Parkinson's disease. It helps manage symptoms such as tremors, stiffness, and difficulty moving. This medication is designed for subcutaneous use, providing targeted relief for those experiencing motor fluctuations associated with Parkinson's disease.
What are the side effects of Apomorphine Hydrochloride Hemihydrate?
Common effects of Apo-Go Pod may include nausea, dizziness, and injection site reactions. Some users may also experience drowsiness or lightheadedness. These effects can vary depending on individual tolerance and usage.
What precautions apply to Apomorphine Hydrochloride Hemihydrate?
Apo-Go Pod should be handled with care, ensuring proper storage and administration techniques. It is important to follow the prescribed guidelines for subcutaneous use to minimize the risk of side effects. Always consult a healthcare provider for personalized advice.
What does Apomorphine Hydrochloride Hemihydrate interact with?
Apo-Go Pod may interact with other medications, including those that affect blood pressure or cause drowsiness. Alcohol and certain CYP inhibitors might also influence its effectiveness. Always inform your healthcare provider about all medications you are taking.



